IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
暂无分享,去创建一个
M. Roberti | M. Bianchini | E. Levy | J. Mordoh | R. Chacón | Y. Rocca | Mora Amat | M. B. Pampena | J. Loza | F. Coló | V. Fabiano | C. M. Loza | J. Arriaga | M. M. Barrio | A. Bravo | E. Domenichini | M. Pampena